Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Cancer Epidemiol. 2016 Jul 13;43:105–111. doi: 10.1016/j.canep.2016.06.009

Table 2.

Association of NSAID use with liver cancer risk, CPRD

Cases (n = 1195)
No.
Controls (n = 4640)
No.
Crude OR (95% CI)a Adjusted OR (95% CI)b
NSAID use
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 2+ prescriptions 757 2754 1.24 (1.08–1.43) 1.05 (0.88–1.24)
 No. of prescriptions
  2–9 297 1158 1.15 (0.97–1.37) 1.01 (0.83–1.23)
  10–19 139 432 1.46 (1.17–1.83) 1.30 (1.00–1.69)
  20–39 126 481 1.20 (0.96–1.52) 0.97 (0.74–1.27)
   ≥40 195 683 1.33 (1.07–1.65) 1.00 (0.77–1.31)
Ptrend 0.03 0.81
Recency of NSAID use
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 Current NSAID use 449 1701 1.19 (1.01–1.39) 0.98 (0.81–1.18)
 No. of prescriptions
  2–9 96 408 1.03 (0.81–1.32) 0.86 (0.65–1.14)
  10–19 85 300 1.28 (0.98––1.67) 1.21 (0.89–1.64)
  20–39 97 382 1.18 (0.91–1.52) 0.94 (0.70–1.27)
  ≥ 40 171 611 1.32 (1.06–1.66) 1.01 (0.77–1.33)
Ptrend 0.04 0.89
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 Past NSAID use 308 1053 1.33 (1.12–1.59) 1.15 (0.94–1.40)
 No. of prescriptions
  2–9 201 750 1.24 (1.02–1.50) 1.11 (0.89–1.39)
  10–19 54 132 1.93 (1.37–2.71) 1.51 (1.02–2.23)
  20–39 29 99 1.36 (0.88–2.10) 1.09 (0.68–1.77)
  ≥ 40 24 72 1.60 (0.98–2.61) 1.06 (0.61–1.87)
Ptrend 0.04 0.95
Intensity of NSAID use
 Time between first and last prescription: <2 years
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 2+ prescriptions 143 484 1.30 (1.05–1.61) 1.16 (0.91–1.48)
 No. of prescriptions
  2–9 122 417 1.30 (1.03–1.63) 1.18 (0.91–1.52)
  10–19 17 54 1.39 (0.79–2.43) 1.10 (0.57–2.10)
  20–39 4 13 1.38 (0.43–4.39) 1.19 (0.34–4.18)
  ≥ 40 0 0 NA NA
Ptrend 0.08 0.35
 Time between first and last prescription: 2–5 years
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 2+ prescriptions 170 579 1.30 (1.06–1.59) 1.15 (0.91–1.45)
 No. of prescriptions
  2–9 69 284 1.07 (0.80–1.43) 0.90 (0.65–1.25)
  10–19 43 119 1.62 (1.12–2.35) 1.66 (1.10–2.51)
  20–39 42 123 1.55 (1.07–2.24) 1.32 (0.86–2.00)
  ≥40 16 53 1.33 (0.74–2.38) 1.16 (0.60–2.22)
Ptrend 0.02 0.24
 Time between first and last prescription: >5 years
 0–1 prescriptions 438 1886 1.00 (Ref) 1.00 (Ref)
 2+ prescriptions 444 1691 1.19 (1.00–1.41) 0.92 (0.75–1.14)
 No. of prescriptions
  2–9 106 457 1.05 (0.82–1.35) 0.88 (0.66–1.17)
  10–19 79 259 1.38 (1.04–1.83) 1.14 (0.82–1.58)
  20–39 80 345 1.05 (0.80–1.39) 0.81 (0.58–1.11)
  ≥40 179 630 1.31 (1.04–1.64) 0.95 (0.72–1.25)
Ptrend 0.03 0.80

Abbreviations: CI = confidence interval; CPRD = Clinical Practice Research Datalink; OR = odds ratio.

a

Using conditional logistic regression to account for matching.

b

Using conditional logistic regression to account for matching, and additionally adjusted for body mass index, smoking status, alcohol-related disorders, hepatitis B or C virus infection, diabetes, rare metabolic disorders, and use of paracetamol, antidiabetic medications, and statins.

HHS Vulnerability Disclosure